|
|
Post by lakers on Apr 7, 2017 16:34:51 GMT -5
As promised! files.shareholder.com/downloads/AMDA-22AIJ9/3642147103x0xS1193125-17-116196/899460/filing.pdffiles.shareholder.com/downloads/AMDA-22AIJ9/3642147103x0xS1193125-17-116337/899460/filing.pdfDate: May 18, 2017 Time: 10:00 A.M. (Eastern Daylight Time) Place: MannKind Corporation, 40 Taylor Street, Danbury, CT 06810 The purpose of the Annual Meeting is to take action on the following proposals: Proposal 1 – To elect the seven nominees named herein as directors to serve for the ensuing year and until their successors are elected; 01 Matthew J. Pfeffer 04 Michael A. Friedman, MD 07 Henry L. Nordhoff 02 James S. Shannon, MD, MRCP (UK) 05 Kent Kresa 03 Ronald J. Consiglio 06 David H. MacCallum Proposal 2 – To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in MannKind’s proxy statement for the Annual Meeting; Proposal 3 – To indicate, on an advisory basis, the preferred frequency of stockholder advisory vote on the compensation of the named executive officers of MannKind; and Proposal 4 – To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of MannKind for its fiscal year ending December 31, 2017. The Board of Directors recommends that you vote FOR all nominees in proposal 1, one year for proposal 3, and FOR proposals 2 and 4. |
|
|
|
Post by kc on Apr 7, 2017 16:45:17 GMT -5
Shareholders of record March 27, 2017 can vote.
|
|
|
|
Post by boytroy88 on Apr 7, 2017 16:53:50 GMT -5
As promised! files.shareholder.com/downloads/AMDA-22AIJ9/3642147103x0xS1193125-17-116196/899460/filing.pdffiles.shareholder.com/downloads/AMDA-22AIJ9/3642147103x0xS1193125-17-116337/899460/filing.pdfDate: May 18, 2017 Time: 10:00 A.M. (Eastern Daylight Time) Place: MannKind Corporation, 40 Taylor Street, Danbury, CT 06810 The purpose of the Annual Meeting is to take action on the following proposals: Proposal 1 – To elect the seven nominees named herein as directors to serve for the ensuing year and until their successors are elected; 01 Matthew J. Pfeffer 04 Michael A. Friedman, MD 07 Henry L. Nordhoff 02 James S. Shannon, MD, MRCP (UK) 05 Kent Kresa 03 Ronald J. Consiglio 06 David H. MacCallum Proposal 2 – To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in MannKind’s proxy statement for the Annual Meeting; Proposal 3 – To indicate, on an advisory basis, the preferred frequency of stockholder advisory vote on the compensation of the named executive officers of MannKind; and Proposal 4 – To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of MannKind for its fiscal year ending December 31, 2017. The Board of Directors recommends that you vote FOR all nominees in proposal 1, one year for proposal 3, and FOR proposals 2 and 4. Sorry, I read it but am not getting why it's as positive as it seems to some of you. |
|
|
|
Post by taxon on Apr 7, 2017 16:57:25 GMT -5
Any reason for concern that the last DEF 14A shows Mann holdings at ~89.6M and 114.1M respectively prior to the 1:5 split and on this form released today it is showing the same shares for the foundation/trust? The reason this stands out is that all of the other Executives and BOD shares counts have been reduced to roughly the 1:5 ratio, but the Mann's have not. Not trying to be controversial, but in relation to the 8K on change of control agreement.... that might be good information have...
|
|
|
|
Post by silentknight on Apr 7, 2017 17:02:05 GMT -5
I'll be voting no for the directors. It won't matter but I can't support them remaining as members after the last couple of years of shareholder destruction and terrible decisions.
The Mann Group will have the final say, but I'm hoping someone there is as fed up as the rest of us and exercises some authority.
|
|
|
|
Post by sayhey24 on Apr 7, 2017 17:03:39 GMT -5
Any reason for concern that the last DEF 14A shows Mann holdings at ~89.6M and 114.1M respectively prior to the 1:5 split and on this form released today it is showing the same shares for the foundation/trust? The reason this stands out is that all of the other Executives and BOD shares counts have been reduced to roughly the 1:5 ratio, but the Mann's have not. Not trying to be controversial, but in relation to the 8K on change of control agreement.... that might be good information have... typical MNKD typo |
|
|
|
Post by sayhey24 on Apr 7, 2017 17:07:16 GMT -5
As promised! files.shareholder.com/downloads/AMDA-22AIJ9/3642147103x0xS1193125-17-116196/899460/filing.pdffiles.shareholder.com/downloads/AMDA-22AIJ9/3642147103x0xS1193125-17-116337/899460/filing.pdfDate: May 18, 2017 Time: 10:00 A.M. (Eastern Daylight Time) Place: MannKind Corporation, 40 Taylor Street, Danbury, CT 06810 The purpose of the Annual Meeting is to take action on the following proposals: Proposal 1 – To elect the seven nominees named herein as directors to serve for the ensuing year and until their successors are elected; 01 Matthew J. Pfeffer 04 Michael A. Friedman, MD 07 Henry L. Nordhoff 02 James S. Shannon, MD, MRCP (UK) 05 Kent Kresa 03 Ronald J. Consiglio 06 David H. MacCallum Proposal 2 – To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in MannKind’s proxy statement for the Annual Meeting; Proposal 3 – To indicate, on an advisory basis, the preferred frequency of stockholder advisory vote on the compensation of the named executive officers of MannKind; and Proposal 4 – To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of MannKind for its fiscal year ending December 31, 2017. The Board of Directors recommends that you vote FOR all nominees in proposal 1, one year for proposal 3, and FOR proposals 2 and 4. Sorry, I read it but am not getting why it's as positive as it seems to some of you. free doughnuts and bagels and a field trip to beautiful Danbury |
|
|
|
Post by boca1girl on Apr 7, 2017 17:08:55 GMT -5
Wasn't someone saying to look at the proxy information for an authorization vote on additional shares? I guess it's good news that they are not asking for new shares to be authorized.
|
|
|
|
Post by saxcmann on Apr 7, 2017 17:14:24 GMT -5
The Mann Group will have the final say, but I'm hoping someone there is as fed up as the rest of us and exercises some authority. I have reason to believe they are... |
|
|
|
Post by lakers on Apr 7, 2017 17:15:57 GMT -5
Wasn't someone saying to look at the proxy information for an authorization vote on additional shares? I guess it's good news that they are not asking for new shares to be authorized. That could very well indicate no new share needed (considering Cash will run out by July and Notes due this year) due to large cash infusion for > 50% stake resulting in Change of Control ? |
|
|
|
Post by barnstormer on Apr 7, 2017 17:34:54 GMT -5
Sounds to me like they are setting up to go private.
|
|
|
|
Post by goyocafe on Apr 7, 2017 17:45:55 GMT -5
Sounds to me like they are setting up to go private. Wouldn't that require a vote, even if for just formality sake? |
|
|
|
Post by sayhey24 on Apr 7, 2017 18:05:00 GMT -5
Sounds to me like they are setting up to go private. Wouldn't that require a vote, even if for just formality sake? Of course it would. It would be brought up as new business on 5/18 during the meeting. The first thing that struck me is the ASM being in May, its always in June. Matt brought up 5/18 during the last call. During bad years the ASM is always held in Valencia. I am not sure whats going to happen but I think I will at least get a free doughnut or maybe I will Go Big and have a bagel. One thing we have learned since approval is afrezza works better than anyone expected. As Kevin Sayers has said no one has ever seen anything like it. One thing SNY learned in the last two years is Toujeo is a flop and Tresiba is eating their lunch as they continue to see falling Lantus sales. Real-time sensor technology has pulled the curtain back on current treatments and there will be no turning back. Soon they will supplant current meters and insurance will require PWDs to be cloud monitored. Has Matt found one of those old Top Hats which they use to make in the Danbury plant and is he about to pull a rabbit out of it? Something is going on with no vote to increase outstanding shares. |
|
|
|
Post by lakers on Apr 7, 2017 18:14:10 GMT -5
No poison pill in place either. It seems BoD wants Mnkd to be taken over.
|
|
|
|
Post by derek2 on Apr 7, 2017 18:38:05 GMT -5
No poison pill in place either. It seems BoD wants Mnkd to be taken over. From the latest 10-K Also, MNKD has had Change of Control agreements in place with key employees for over a decade. Today's form 8 is a renewal and update. |
|
